Contract Services Clinical Research
Eisai Co., Ltd. and Biogen Inc. announced today that the Ministry of Health and Prevention in the United Arab Emirates (UAE) has approved humanized anti-so...
August 14, 2024 | News
Pulnovo Medical Limited,a globally recognized device pioneer in the treatment of Pulmonary Hypertension (PH) and Heart Failure (HF), is pleased to announce...
August 10, 2024 | News
Partnership leverages Medigene's leadership for T cell receptor (TCR) generation and characterization and WuXi Biologics' unique anti-CD3 mAb, its T cell...
August 09, 2024 | News
Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, in partnership with Illumina, a leader in DNA...
August 07, 2024 | News
Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious disea...
August 07, 2024 | News
Leica Microsystems, a leader in microscopy and scientific instrumentation, has released Mateo FL, an AI-powered digital fluorescence microscope for cell cu...
August 06, 2024 | News
Oxford Nanopore Technologies (Oxford Nanopore) has announced a landmark project with Singapore's National Precision Medicine (NPM) programme, led by Precis...
August 05, 2024 | News
The New Drug Application (NDA) includes data from the Phase III studies OASIS 1, 2 and 3 - showing elinzanetant significantly reduced the frequency...
August 02, 2024 | News
Biosyngen has announced a strategic collaboration with Singapore's Agency for Science, Technology and Research (A*STAR) to enhance autoimmune the...
August 02, 2024 | News
Sirnaomics Ltd. (the "Company", Stock Code: 2257.HK, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical co...
August 01, 2024 | News
The Singapore Clinical Research Institute (SCRI), together with its sister programme, the Cardiovascular Disease National Collaborative Enterprise (CADENCE...
July 31, 2024 | News
United States-based National Comprehensive Cancer Network strengthens relationship with Chinese medical platform Medlive to broaden access to eminent oncol...
July 31, 2024 | News
-- Achieved primary endpoint of LS mean reduction in LDL-C on top of maximally tolerated lipid modifying therapies at week 12 with statistically ...
July 30, 2024 | News
Akeso (9926.HK) is delighted to announce that the supplemental biologics license application (sBLA) for its independently developed, world's first-in-class...
July 30, 2024 | News
Most Read
Bio Jobs
News
Editor Picks